|
|
Studies
|
|
 |
|
New Programs(25 Records found)
CTO#: 101766
Status: Active/Enrolling
Sponsor: RTOG (0938)
A Randomized Phase II Trial of Hypofractionated Radiotherapy for Favorable Risk Prostate Cancer
Lay Description:
HIPAA
Informed Consent
...details...
CTO#: 101747
Status: Active/Enrolling
Sponsor: NSABP (P-5)
Statin Polyp Prevention Trial in Patients with Resected Colon Cancer
Lay Description:
HIPAA
Informed Consent
Protocol
...details...
CTO#: 101746
Status: Active/Enrolling
Sponsor: MUSC (TMS-2011-B)
Characterization of Peripheral Blood Monocytosis and Reactive Lymphocytosis in Patients with Mast Cell Activation Syndrome (MCAS)
Lay Description: This study is evaluating if flow cytometric techniques can quickly and accurately distinguish mast cells from monocytes and reactive lymphocytes and provide the health care team a way to detect mast cell activation sydrome(MCAS) earlier and provide better outcomes. This study requires a blood sample from suspected MCAS patients.
HIPAA
Informed Consent
Protocol
...details...
CTO#: 101745
Status: Active/Enrolling
Sponsor: MUSC (TMS-2011-A)
Retrospective Characterization of Certain Blood Test Abnormalities Potentially Aiding the Diagnosis of Mast Cell Activation Disease (MCAD), Especially Mast Cell Activation Syndrome (MCAS)
Lay Description:
No Documents currently available
...details...
CTO#: 101716
Status: Active/Enrolling
Sponsor: NCCTG (020221)
A Phase II Clinical Trial Evaluating DCVax®-Brain, Autologous Dendritic Cells Pulsed with Tumor Lysate Antigen for the Treatment of Glioblastoma Multiforme
Lay Description:
No Documents currently available
...details...
CTO#: 101705
Lip, Oral Cavity and Pharynx
Status: Active/Enrolling
Sponsor: RTOG (1016)
PHASE III TRIAL OF RADIOTHERAPY PLUS CETUXIMAB VERSUS CHEMORADIOTHERAPY IN HPV-ASSOCIATED OROPHARYNX CANCER
Lay Description:
HIPAA
Informed Consent
Protocol
...details...
CTO#: 101697
Status: Active/Enrolling
Sponsor: Eli Lilly (I3X-MC-JHTC)
A Phase 1 Study of LY2784544 Testing Alternative Dosing
Regimens in Patients with Myelofibrosis
Lay Description:
HIPAA
Informed Consent
Patient Materials
Protocol
Sub Study Consent
...details...
CTO#: 101669
Status: Active/Enrolling
Sponsor: MUSC (Onyx IST-CAR-536)
Phase 1/2A Study Carfilzomib + High Dose Melphalan as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
Lay Description:
No Documents currently available
...details...
CTO#: 101665
Brain and Nervous System
Status: Active/Enrolling
Sponsor: MUSC ()
The Efficacy of PF-02341066 (Crizotinib), a Dual ALK/c-Met Inhibitor in Inhibiting Growth of Glioblastoma
Lay Description:
No Documents currently available
...details...
CTO#: 101663
Status: Active/Enrolling
Sponsor: CALGB (80803)
RANDOMIZED PHASE II TRIAL OF PET SCAN-DIRECTED COMBINED MODALITY THERAPY IN ESOPHAGEAL CANCER
Lay Description:
HIPAA
Informed Consent
Protocol
...details...
CTO#: 101657
Status: Active/Enrolling
Sponsor: SWOG (S1014)
Abiraterone Acetate Treatment for Prostate Cancer Patients with a
PSA of More Than Four Following Initial Androgen Deprivation Therapy,
Phase II.
Lay Description:
HIPAA
Informed Consent
Protocol
...details...
CTO#: 101646
Status: Active/Enrolling
Sponsor: Threshold Pharmaceuticals (TH-CR-406/SARC021)
A Randomized Phase 3, Multicenter, Open-Label Study Comparing TH-302 in Combination with Doxorubicin vs. Doxorubicin Alone in Subjects with Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma
Lay Description:
HIPAA
Informed Consent
Protocol
...details...
CTO#: 101640
Lip, Oral Cavity and Pharynx
Status: Active/Enrolling
Sponsor: RTOG (1008)
A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
Lay Description:
HIPAA
Informed Consent
Protocol
...details...
CTO#: 101639
Other Hematopoietic
Status: Active/Enrolling
Sponsor: Incyte (INCB 18424-261)
An Open Label Assessment of an Alternative Dosing Strategy of Ruxolitinib in Patients With Primary Myelofibrosis, Post-Polycythemia Vera-Myelofibrosis and Post-Essential Thrombocythemia-Myelofibrosis
Lay Description:
HIPAA
Informed Consent
Protocol
...details...
CTO#: 101635
Breast-Female
Status: Active/Enrolling
Sponsor: MUSC ()
Feasibility Study of Breast Cancer Candidate Genes in Three Population Groups In South Carolina
Lay Description:
No Documents currently available
...details...
CTO#: 101633
Breast-Female
Status: Active/Enrolling
Sponsor: ECOG (E2108)
A Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer
Lay Description:
HIPAA
Informed Consent
Protocol
...details...
CTO#: 101632
Status: Active/Enrolling
Sponsor: MUSC ()
Impact of nutritional parameters on outcome after pediatric hematopoietic stem cell transplantation
Lay Description:
No Documents currently available
...details...
CTO#: 101629
Breast-Female
Status: Active/Enrolling
Sponsor: RTOG (1005)
A Phase III Trial of Accelerated Whole Breast Irradiation with Hypofractionation Plus Concurrent Boost Versus Standard Whole Breast Irradiation Plus Sequential Boost for Early-Stage Breast Cancer.
Lay Description:
HIPAA
Informed Consent
Protocol
...details...
CTO#: 101628
Breast-Female
Status: Active/Enrolling
Sponsor: SWOG (S1007)
A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Postive Nodes, Hormone Receptor-Positive and HER2 negative Breast Cancer with Recurrence Score of 25 or less.
Lay Description:
HIPAA
Informed Consent_Step 1
Informed Consent_Step 2
Protocol
...details...
CTO#: 101626
Status: Active/Enrolling
Sponsor: Oncothyreon Inc. (PX-866-003)
Phase 1/2 study of PX-866 and cetuximab
Lay Description:
HIPAA
Informed Consent
Patient Instructions
Protocol
...details...
CTO#: 101625
Status: Active/Enrolling
Sponsor: MUSC ()
The Accuracy of Virtual Guided Bronchoscopy (Broncus) compared to Endobronchial Ultrasound Guided Transbronchial Needle Aspiration for Mediastinal Lymph Nodes
Lay Description:
No Documents currently available
...details...
CTO#: 101622
Breast-Female
Status: Active/Enrolling
Sponsor: MUSC ()
Paclitaxel Induced Peripheral Neuropathy in Breast Cancer: Exploratory Study of the Role of Deoxysphingolipids
Lay Description:
HIPAA
Informed Consent
Protocol
...details...
CTO#: 101619
Lymphoid Leukemia, Non-Hodgkins Lymphoma
Status: Active/Enrolling
Sponsor: Sanofi-Aventis (TCD12012)
A Phase 1b, multicenter, open-label, dose-escalation study of SAR245409 to evaluate the safety, tolerability, and clinical activity of SAR245409 in combination with bendamustine and/or rituximab in patients with relapsed or refractory indolent B-cell non Hodgkin lymphoma, mantle cell lymphoma, or chronic lymphocytic leukemia.
Lay Description:
Consent
HIPAA
Optional Consent
Optional HIPAA
Pregnant Partner HIPAA
Protocol
...details...
CTO#: 101618
Breast-Female
Status: Active/Enrolling
Sponsor: Genentech, Inc. (GDC4950g)
A PHASE II, DOUBLE-BLIND,PLACEBO-CONTROLLED, RANDOMIZED STUDY
OF GDC-0941 OR GDC-0980 WITH FULVESTRANT VERSUS FULVESTRANT IN
ADVANCED OR METASTATIC BREAST CANCER IN PATIENTS RESISTANT TO AROMATASE INHIBITOR THERAPY
Lay Description:
HIPAA
Main Consent
Optional Consent
Protocol
Spanish HIPAA
Spanish Informed Consent
Spanish Patient Materials
...details...
CTO#: 101616
Status: Active/Enrolling
Sponsor: MUSC ()
Exploration of the Association of Periodontal Disease and Colorectal Neoplasia
Lay Description:
No Documents currently available
...details...
|
|
|
|
|
|
 |